Severe alterations in lipid composition of frontal cortex lipid rafts from parkinson's disease and incidental parkinson's

dc.contributor.authorFabelo, Noemí
dc.contributor.authorMartín, Virginia
dc.contributor.authorSantpere Baró, Gabriel
dc.contributor.authorMarín, Raquel
dc.contributor.authorTorrent, Laia
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)
dc.contributor.authorDíaz, Mario
dc.date.accessioned2019-01-25T15:18:45Z
dc.date.available2019-01-25T15:18:45Z
dc.date.issued2010
dc.date.updated2019-01-25T15:18:45Z
dc.description.abstractLipid rafts are cholesterol- and sphingomyelin-enriched microdomains that provide a highly saturated and viscous physicochemical microenvironment to promote protein-lipid and protein-protein interactions. We purified lipid rafts from human frontal cortex from normal, early motor stages of Parkinson's disease (PD) and incidental Parkinson's disease (iPD) subjects and analyzed their lipid composition. We observed that lipid rafts from PD and iPD cortices exhibit dramatic reductions in their contents of n-3 and n-6 long-chain polyunsaturated fatty acids, especially docosahexaenoic acid (22:6-n3) and arachidonic acid (20:4n-6). Also, saturated fatty acids (16:0 and 18:0) were significantly higher than in control brains. Paralleling these findings, unsaturation and peroxidability indices were considerably reduced in PD and iPD lipid rafts. Lipid classes were also affected in PD and iPD lipid rafts. Thus, phosphatidylserine and phosphatidylinositol were increased in PD and iPD, whereas cerebrosides and sulfatides and plasmalogen levels were considerably diminished. Our data pinpoint a dramatic increase in lipid raft order due to the aberrant biochemical structure in PD and iPD and indicate that these abnormalities of lipid rafts in the frontal cortex occur at early stages of PD pathology. The findings correlate with abnormal lipid raft signaling and cognitive decline observed during the development of these neurodegenerative disorders.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec600983
dc.identifier.issn1076-1551
dc.identifier.pmid21717034
dc.identifier.urihttps://hdl.handle.net/2445/127630
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.2119/molmed.2011.00119
dc.relation.ispartofMolecular Medicine, 2010, vol. 17, num. 9-10, p. 1107-1118
dc.relation.urihttps://doi.org/10.2119/molmed.2011.00119
dc.rights(c) Molecular Medicine, 2010
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationMalaltia de Parkinson
dc.subject.classificationColesterol
dc.subject.otherParkinson's disease
dc.subject.otherCholesterol
dc.titleSevere alterations in lipid composition of frontal cortex lipid rafts from parkinson's disease and incidental parkinson's
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
600983.pdf
Mida:
2 MB
Format:
Adobe Portable Document Format